Laboratory testing is important for an accurate diagnosis, determination of treatment success, and autoimmune disease progression. PAML offers advanced testing options in the areas of serology-based immunoassays for antibody and antigen detection. In addition to our immunology and biochemistry-centered testing, we offer ancillary testing in molecular genetics to support an autoimmune diagnosis. Clinical consults are available for the interpretation of testing and recommendations for follow-up testing.
Antiphospholipid syndrome (APS) is an autoimmune disorder associated with a high incidence of thrombotic disease and obstetrical complications. Like many autoimmune diseases, APS can be difficult to diagnose. Current diagnostic criteria rely on both clinical and serologic measures to confirm the presence of APS. PAML offers the most advanced APS tests to give clinicians added clarity in the diagnosis of APS. In addition to the routine tests – lupus anticoagulant, anticardiolipin antibodies, and beta2 glycoprotein – we offer emerging biomarkers PS/PT and beta2 glycoprotein Domain 1. Both of these are highly specific for the diagnosis of APS and may help support therapeutic decision making. For more information on our test menu for APS please click on the links below.